Beryl Drugs Ltd — Important, 12-05-2026: Company Update

Beryl Drugs Limited shareholders have concluded their Extra-Ordinary General Meeting (EGM), confirming the passage of all proposed resolutions. Key approvals include the regularization of Mr. Shailendra Pathak as a Whole Time Director and the appointment of Mrs. Neha Sarda as a Non-Executive Independent Director. Additionally, shareholders gave their assent to a significant related party transaction involving M/S. Aminova Infusions P. Ltd. These decisions underscore strong shareholder support for the company's governance and strategic operational direction.